RxDoctor Payments Data

Garnett Murphy, MD

Foot and Ankle Surgery · Germantown, TNNPI 1952398646

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (49.1%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Stryker accounts for 87.2% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $27,471 and has fallen 56.3% since, to $11,995 in 2025. Among foot and ankle surgery clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$130,401in general payments, 2019–2025

Across 151 payments — averaging $863.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$114K
  • Arthrex$12K
  • Gentleman Orthopedic Solutions$4K
  • Amgen$221
  • Johnson & Johnson$102
  • Treace Medical Concepts, Inc.$102
  • plus $318 from 5 others
$96,364in research payments, 2019–2025

Across 34 payments — averaging $2834.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$93K
  • Ferring International Pharmascience Center US$3K

What the payments were for

  • Royalty or licence$64,03449%
  • Consulting fees$40,86031%
  • Speaking & faculty fees$12,96410%
  • Travel & lodging$2,9302%
  • Food & beverage$4,0353%
  • Education$5,5774%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$130,401 in reported general payments places this provider in the 95th percentile of 145 foot and ankle surgery providers in Tennessee.

See all foot and ankle surgery providers in Tennessee

Medicare billing

Part B allowed, 2024
$452,678
Medicare patients
1,481
Services billed
9,222

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluconazole11$1,646
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen117$1,293
Ibuprofen147$1,210
Ondansetron Hcl134$694
Cephalexin161$417
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen25$320
Meloxicam78$219
Methylprednisolone26$142
Colchicine11$110
Gabapentin20$93

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Germantown

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →